Safety and Immunogenicity of SCB-2019 in Children <18 Years of Age

NCT05193279 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study was terminated during the EC submission process prior to the enrollment.

Conditions

Interventions

Sponsor

Clover Biopharmaceuticals AUS Pty